Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Mechel reported for 9 months of 2024 by RAS

10/28/24 MTLR

MTS launched production of 5G stations

10/28/24 MTSS

DZRD reported for 9 months of 2024 by RAS

10/28/24 DZRD

INARCTICA reported for 9 months of 2024 by RAS

10/28/24 AQUA

European Electrotechnics reported for 9 months of 2024 by RAS

10/28/24 EELT

Nauka-Svyaz reported for 9 months of 2024 by RAS

10/28/24 NSVZ

KSC reported for 9 months of 2024 by RAS

10/28/24 KLSB

Nornickel reported for 9 months of 2024 by RAS

10/28/24 GMKN

Unipro's output decreased by 1%

10/28/24 UPRO

Fesco has accepted the container ship Kapitan Malakhov into its fleet

10/28/24 FESH